Altis Biosystems
PrivateLast Round
Grant
Jul 1, 2023
Total Funding Raised
$4.69M
Company Overview
Altis Biosystems operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Grant round in July 2023.
Altis Biosystems is a biotechnology company that provides a stem cell technology platform, RepliGut®, which recreates the human intestinal epithelium for use in preclinical drug discovery, compound screening, and microbiome research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altis Biosystems Comparables
Compare Altis Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emulate | 85% | |
| Dynamic42 | 85% | |
| MIMETAS | 85% |
For institutional investors. Book with your work email.
Altis Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2023 | ||||
| Debt | Feb 16, 2022 | ||||
| Grant | Feb 2, 2021 | ||||
| Seed | Aug 11, 2020 | ||||
| Grant | Apr 25, 2019 | ||||
Grant | Nov 20, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Altis Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NC IDEA | Grant |
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Hatteras Venture Partners | Seed |
| Central Texas Angel Network | Seed |
| RTP Capital Associates | Seed |
| North Carolina Biotechnology Center | Debt |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 2, 2021
$75K grant received from One North Carolina Small Business Program.
- Apr 25, 2019
$50K grant from One North Carolina Small Business Program.
For institutional investors. Book with your work email.
Altis Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Altis Biosystems's valuation, stock price, and market status.
Is Altis Biosystems a public or private company?
Altis Biosystems is a private company.
What is the current stock price of Altis Biosystems?
Altis Biosystems is a private company, so its shares have no public market price. Caplight tracks Altis Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Altis Biosystems worth (valuation)?
Valuation information for Altis Biosystems is not publicly available.
Can I buy Altis Biosystems stock?
Altis Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Altis Biosystems's last funding round?
Altis Biosystems's most recent funding round was Grant on July 1, 2023.
Who are the main investors in Altis Biosystems?
Key investors in Altis Biosystems include North Carolina Biotechnology Center, VentureSouth.
Will Altis Biosystems IPO soon?
No public IPO plans have been announced for Altis Biosystems.
How can I track Altis Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Altis Biosystems's shares on secondary markets.